SVB Leerink Maintains Outperform on BeiGene, Raises Price Target to $236

SVB Leerink analyst Andrew Berens maintains BeiGene (NASDAQ:BGNE) with a Outperform and raises the price target from $210 to $236.

SVB Leerink analyst Andrew Berens maintains BeiGene (NASDAQ:BGNE) with a Outperform and raises the price target from $210 to $236.

Total
0
Shares
Related Posts